PL360258A1

Anti-il-12 antibodies, compositions, methods and uses

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 7 August 2021, 5.1 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

166 members in 37 offices

This recordMember, by publication datePriority claim27 more offices are in the list below

Priority claims12

Priority claims
DocumentOfficeKindDate
22335800United States of AmericaP
22335800United States of AmericaP
23682700United States of AmericaP
23682700United States of AmericaP
92026201United States of AmericaA
92026201United States of AmericaA
0060233358
0060236827
01920262
US20000223358P
US20000236827P
US20010920262

Members166

Family members, oldest first
DocumentOfficeKind
CA2418961A1CanadaA1
WO0212500A2World Intellectual Property Organization (WIPO)A2
AU8113701AAustraliaA
WO0212500A3World Intellectual Property Organization (WIPO)A3
NO20030614D0NorwayD0
NO20030614LNorwayL
KR20030034133ARepublic of KoreaA
EP1309692A2European Patent Office (EPO)A2
US2003124123A1United States of AmericaA1
AR030134A1ArgentinaA1
EA200300137A1Eurasian Patent Organization (EAPO)A1
IL154325A0IsraelA0
MXPA03001229AMexicoA
HU0302378A2HungaryA2
HUP0302378A2HungaryA2
CN1468309AChinaA
BR0113109ABrazilA
ZA200301867BSouth AfricaB
PL360258A1This recordPolandA1
JP2004527212AJapanA
NZ524145ANew ZealandA
US2005002937A1United States of AmericaA1
US2005112127A1United States of AmericaA1
US6902734B2United States of AmericaB2
US2005196838A1United States of AmericaA1
US2005214293A1United States of AmericaA1
HRP20030087A2CroatiaA2
EA006673B1Eurasian Patent Organization (EAPO)B1
UY29291A1UruguayA1
US7063964B2United States of AmericaB2
AU2005319278A1AustraliaA1
CA2591813A1CanadaA1
WO2006069036A2World Intellectual Property Organization (WIPO)A2
TW200636065ATaiwan Province of ChinaA
US7166285B2United States of AmericaB2
NZ535865ANew ZealandA
AR051805A1ArgentinaA1
AU2001281137B2AustraliaB2
WO2006069036A3World Intellectual Property Organization (WIPO)A3
NO20073778LNorwayL
EP1836294A2European Patent Office (EPO)A2
KR20070094927ARepublic of KoreaA
US7279157B2United States of AmericaB2
MY133377AMalaysiaA
UA81100C2UkraineC2
EA200701363A1Eurasian Patent Organization (EAPO)A1
CN101120087AChinaA
US2008090290A1United States of AmericaA1
KR100823576B1Republic of KoreaB1
JP2008523842AJapanA
BRPI0515858ABrazilA
IL183939A0IsraelA0
CR9265ACosta RicaA
ZA200706036BSouth AfricaB
EP1309692B1European Patent Office (EPO)B1
AT431412TAustriaT
ATE431412T1AustriaT1
PT1309692EPortugalE
DK1309692T3DenmarkT3
EP1836294A4European Patent Office (EPO)A4
DE60138711D1GermanyD1
NL300390I1Netherlands (Kingdom of the)I1
US7560247B2United States of AmericaB2
ES2323760T3SpainT3
US2009202549A1United States of AmericaA1
EP2090657A2European Patent Office (EPO)A2
SI1309692T1SloveniaT1
LU91584I2LuxembourgI2
DE122009000025I1GermanyI1
FR09C0021I1FranceI1
CN101550190AChinaA
CA2418961CCanadaC
US2009274707A1United States of AmericaA1
SG158150A1SingaporeA1
NL300390I2Netherlands (Kingdom of the)I2
RS50477BSerbiaB
NZ555658ANew ZealandA
FR09C0021I2FranceI2
HK1135991AHong Kong, ChinaA
HK1135991A1Hong Kong, ChinaA1
TWI329672BTaiwan Province of ChinaB
IL154325AIsraelA
US7887807B2United States of AmericaB2
EP2305817A2European Patent Office (EPO)A2
US2011082190A1United States of AmericaA1
NZ583153ANew ZealandA
JP4731094B2JapanB2
NO330903B1NorwayB1
JP2011173884AJapanA
NO2011023I2NorwayI2
NO2011023I1NorwayI1
US8080247B2United States of AmericaB2
US8084233B2United States of AmericaB2
EP2090657A3European Patent Office (EPO)A3
EP2305817A3European Patent Office (EPO)A3
EA016022B1Eurasian Patent Organization (EAPO)B1
JP2012025779AJapanA
US2012063998A1United States of AmericaA1
AU2012203565A1AustraliaA1
HRP20030087B1CroatiaB1
Showing 100 of 166